Movement Alert｜3SBio Rises 5.53% in Regular Trading, Biotech Sector Broadly Rallies Amid Supportive Corporate Actions

Market Focus07-10

On July 10, 3SBio rose 5.53% in regular trading, reaching HKD 17.98/share, with turnover of HKD 369 million. The stock advanced alongside a broad biotech sector rally, with PEGBIO surging 41.23%, Remegen up 7.14%, Akeso up 5.39%, Innovent Bio up 4.69%, and BeiGene up 2.64%.

The move comes amid multiple recent positive corporate actions. In June, 3SBio repurchased approximately 8.52 million shares at prices between HKD 15.52 and HKD 16.00, holding them as treasury stock. The company also declared a final dividend of HKD 0.25 per share payable on August 4. Additionally, Chairman Lou Jing increased his stake by 516,000 shares in early June at HKD 15.25 per share, while institutional investor Hui Tian Fu Fund raised its holding to 7% of issued shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187068094?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 10:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187068094","market":"us","top_or_hot":-1,"title":"Movement Alert｜3SBio Rises 5.53% in Regular Trading, Biotech Sector Broadly Rallies Amid Supportive Corporate Actions","media":"Market Focus","content":"<p><p>On July 10, 3SBio rose 5.53% in regular trading, reaching HKD 17.98/share, with turnover of HKD 369 million. The stock advanced alongside a broad biotech sector rally, with PEGBIO surging 41.23%, Remegen up 7.14%, Akeso up 5.39%, Innovent Bio up 4.69%, and BeiGene up 2.64%.</p><p>The move comes amid multiple recent positive corporate actions. In June, 3SBio repurchased approximately 8.52 million shares at prices between HKD 15.52 and HKD 16.00, holding them as treasury stock. The company also declared a final dividend of HKD 0.25 per share payable on August 4. Additionally, Chairman Lou Jing increased his stake by 516,000 shares in early June at HKD 15.25 per share, while institutional investor Hui Tian Fu Fund raised its holding to 7% of issued shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜3SBio Rises 5.53% in Regular Trading, Biotech Sector Broadly Rallies Amid Supportive Corporate Actions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜3SBio Rises 5.53% in Regular Trading, Biotech Sector Broadly Rallies Amid Supportive Corporate Actions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-10 10:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 10, 3SBio rose 5.53% in regular trading, reaching HKD 17.98/share, with turnover of HKD 369 million. The stock advanced alongside a broad biotech sector rally, with PEGBIO surging 41.23%, Remegen up 7.14%, Akeso up 5.39%, Innovent Bio up 4.69%, and BeiGene up 2.64%.</p><p>The move comes amid multiple recent positive corporate actions. In June, 3SBio repurchased approximately 8.52 million shares at prices between HKD 15.52 and HKD 16.00, holding them as treasury stock. The company also declared a final dividend of HKD 0.25 per share payable on August 4. Additionally, Chairman Lou Jing increased his stake by 516,000 shares in early June at HKD 15.25 per share, while institutional investor Hui Tian Fu Fund raised its holding to 7% of issued shares.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1187068094","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187068094","pubTimestamp":1783651695,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, 3SBio rose 5.53% in regular trading, reaching HKD 17.98/share, with turnover of HKD 369 million. The stock advanced alongside a broad biotech sector rally, with PEGBIO surging 41.23%,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"走势警报|3SBio 常规交易中上涨 5.53%，生物技术板块在企业支持性行动中普遍上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"On July 10, 3SBio rose 5.53% in regular trading, reaching HKD 17.98/share, with turnover of HKD 369 million. The stock advanced alongside a broad biotech sector rally, with PEGBIO surging 41.23%, Remegen up 7.14%, Akeso up 5.39%, Innovent Bio up 4.69%, and BeiGene up 2.64%.The move comes amid multiple recent positive corporate actions. In June, 3SBio repurchased approximately 8.52 million shares at prices between HKD 15.52 and HKD 16.00, holding them as treasury stock. The company also declared a final dividend of HKD 0.25 per share payable on August 4. Additionally, Chairman Lou Jing increased his stake by 516,000 shares in early June at HKD 15.25 per share, while institutional investor Hui Tian Fu Fund raised its holding to 7% of issued shares.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187068094","isCrawlerRequest":true}